Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;104(1):115742.
doi: 10.1016/j.diagmicrobio.2022.115742. Epub 2022 Jun 12.

Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department

Aurore Bousquet  1 , Sébastien Larréché  2 , Christine Bigaillon  2 , Alexandre Woloch  3 , Léa Thomas  3 , Pierre Louis Conan  4 , Audrey Mérens  2
Affiliations

Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department

Aurore Bousquet et al. Diagn Microbiol Infect Dis. 2022 Sep.

Abstract

We compared ID Now™ and Hologic® Panther Aptima™ for the detection of SARS-COV-2. ID Now™ showed a positive and negative percent agreement of 86.9% and 99.7% respectively. This facilitates faster clinical decision-making, along with the rapid implementation of infection control measures, and improvement of patient flow in the emergency department toward inpatient wards.

Keywords: COVID-19; Hologic Panther Point of care device; ID NOW; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interests All authors declared that there is no conflict of interest in conducting this study.

References

    1. Hologic. Aptima SARS CoV 2 assay - instruction for use 2021.
    1. Kanwar N, Banerjee D, Sasidharan A, Abdulhamid A, Larson M, Lee B, et al. Comparison of diagnostic performance of five molecular assays for detection of SARS-CoV-2. Diagn Microbiol Infect Dis. 2021;101 doi: 10.1016/j.diagmicrobio.2021.115518. - DOI - PMC - PubMed
    1. Abbott. Abbott. ID NOW COVID-19 product insert. 2020.
    1. Harrington A, Cox B, Snowdon J, Bakst J, Ley E, Grajales P, et al. Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients. J Clin Microbiol. 2020;58 doi: 10.1128/JCM.00798-20. - DOI - PMC - PubMed
    1. Aupaix A, Lazarova E, Chemais M. A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test. J Virol Methods. 2021;298 doi: 10.1016/j.jviromet.2021.114293. - DOI - PMC - PubMed